Your browser doesn't support javascript.
loading
Screening for Thyroid Disorders Among Resistant Hypertension Patients: Are We Doing Enough?
Pappan, Nikos; Din, Mian Tanveer Ud; Venkat, Divya; Wedgeworth, Patrick; Fu, Sheng.
Afiliación
  • Pappan N; Medicine Institute, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, USA Nikos.Pappan@ahn.org.
  • Din MTU; Medicine Institute, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, USA.
  • Venkat D; Medicine Institute, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, USA.
  • Wedgeworth P; Medicine Institute, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, USA.
  • Fu S; Cardiovascular Institute, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA USA.
Clin Med Res ; 20(2): 70-73, 2022 06.
Article en En | MEDLINE | ID: mdl-34996821
Objective: To perform a quality assurance study assessing if hypo- and hyperthyroidism are appropriately screened for in patients with resistant hypertension.Design: Data was collected from patients diagnosed with resistant hypertension, defined as being on four or more different classes of anti-hypertensive medications. These patients were filtered to determine if thyroid stimulating hormone (TSH) measurement occurred within 90 days of the addition of a fourth medication class.Setting: Two internal medicine residency clinics in Pittsburgh, PA.Participants: Patients were selected who had a diagnosis of hypertension and were seen in clinic between January 1, 2018 and December 23, 2020.Methods: A single center retrospective review was performed.Results: A total of 1,125 patients were identified as having resistant hypertension. Of these, only 74 patients were found to have a TSH measurement taken within 90 days of having a fourth medication class prescribed. Seven TSH values were found to be abnormal with one patient being diagnosed with hyperthyroidism, demonstrating a screening rate of 6.6%. There were statistically significant differences in age, body mass index, and diastolic blood pressure in those screened versus not.Conclusions: Thyroid disease is under-screened as an etiology for resistant hypertension, particularly given the ease of diagnosis and reversibility of these conditions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de la Tiroides / Hipertensión / Hipertiroidismo Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Clin Med Res Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de la Tiroides / Hipertensión / Hipertiroidismo Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Clin Med Res Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos